1,634 results on '"Velakoulis, Dennis"'
Search Results
152. A phase 1b open‐label study of sodium selenate as a disease‐modifying treatment for possible behavioral variant frontotemporal dementia
153. The Diagnostic Challenge of Young-Onset Dementia Syndromes and Primary Psychiatric Diseases: Results From a Retrospective 20-Year Cross-Sectional Study
154. List of Contributors
155. Beyond Dopamine
156. The ENIGMA‐Epilepsy working group: Mapping disease from large data sets
157. Contributors
158. Neuroanatomical abnormalities in schizophrenia: A multimodal voxelwise meta-analysis and meta-regression analysis
159. The neuropsychiatry of neuroacanthocytosis syndromes
160. Shape analysis of the neostriatum in subtypes of frontotemporal lobar degeneration: Neuroanatomically significant regional morphologic change
161. Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy
162. Shape alterations in the striatum in chorea-acanthocytosis
163. Utility and validity of a brief cognitive assessment tool in patients with epileptic and nonepileptic seizures
164. A case of Cotard syndrome associated with central pontine myelinolysis as a result of normally corrected hyponatremia
165. Confirming Pathogenicity of the F386L PSEN1 Variant in a South Asian Family With Early-Onset Alzheimer Disease
166. The diagnostic challenge among young onset dementia syndromes and primary psychiatric diseases: Results of a retrospective, 20‐year cross‐sectional study
167. Could cerebrospinal fluid neurofilament light chain reduce misdiagnosis in neurodegenerative and neuropsychiatric disorders in a real‐world setting? A retrospective clinical and diagnostic utility study
168. Mortality in FTD: An Australian perspective
169. Dynamics between Neuropsychiatric Symptoms and Biomarkers: A Pilot Study
170. A phase 1b open label study of sodium selenate as a disease‐modifying treatment for behavioural variant fronto‐temporal dementia
171. Sodium selenate as a disease-modifying treatment for mild–moderate Alzheimer’s disease: an open-label extension study
172. Sex differences in survival in younger‐onset dementia
173. Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial
174. Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives
175. Psychiatric symptoms are the strongest predictors of quality of life in patients with drug-resistant epilepsy or psychogenic nonepileptic seizures: Authors’ response
176. 404 - Factors associated with diagnostic delay in younger-onset dementia iagnostic delay in younger-onset dementia
177. Hyperphosphorylated Tau is Implicated in Acquired Epilepsy and Neuropsychiatric Comorbidities
178. Short-Term White Matter Alterations in Alzheimerʼs Disease Characterized by Diffusion Tensor Imaging
179. Heschl's gyrus duplication pattern and clinical characteristics in borderline personality disorder: A preliminary study.
180. Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
181. Epilepsy and Personality
182. Theory of mind in Parkinson’s disease: A meta-analysis
183. Hippocampal pathology in individuals at ultra-high risk for psychosis: A multi-modal magnetic resonance study
184. Shape analysis of the neostriatum in frontotemporal lobar degeneration, Alzheimer's disease, and controls
185. Caudate nucleus volume in individuals at ultra-high risk of psychosis: A cross-sectional magnetic resonance imaging study
186. Corpus callosum morphology and relationship to orbitofrontal and lateral ventricular volume in teenagers with first-presentation borderline personality disorder
187. The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study
188. Pituitary volume in patients with bipolar disorder and their first-degree relatives
189. Mortality in dementia is predicted by older age of onset and cognitive presentation
190. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder should be an accepted therapy in Australia
191. Investigating the clinical utility of biomarkers and other novel tests in younger onset neurocognitive disorders: the BeYOND study, protocol for a longitudinal clinical study in a real-world setting
192. Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia
193. An MRI study of the superior temporal subregions in first-episode patients with various psychotic disorders
194. Theory of mind in behavioural-variant frontotemporal dementia and Alzheimerʼs disease: a meta-analysis
195. Morphometric abnormalities and hyperanxiety in genetically epileptic rats: A model of psychiatric comorbidity?
196. Increased pituitary volume in schizophrenia spectrum disorders
197. Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia
198. Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals
199. Corpus callosum size and shape in first-episode affective and schizophrenia-spectrum psychosis
200. Attentional set-shifting ability in first-episode and established schizophrenia: Relationship to working memory
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.